Year: 2023

The drug, which will be sold as Qalsody by the pharmaceutical company Biogen, targets a genetic cause of a devastating neurological illness. View original article Contributor: Rebecca Robbins

The California health care organization will create a new nonprofit that aims to acquire a half-dozen additional community health systems. View original article Contributor: Reed Abelson

People who take the over-the-counter supplement melatonin for better sleep may be getting more—or less—of the drug than they think, according to a new study published Apr. 24 in JAMA. In an analysis of 25 different gummy supplements claiming to contain melatonin, researchers at the Cambridge Health Alliance and the University of Mississippi found that … Read more

Biogen Inc.’s drug for a rare form of amyotrophic lateral sclerosis was approved by U.S. regulators, marking the first clearance of a treatment targeting a specific genetic cause of the incurable paralysis disease. The Food and Drug Administration granted clearance for the drug, called Qalsody, through an accelerated approval pathway, meaning Biogen must conduct more … Read more

Nearly two years after he’d been treated for kidney cancer and felt like he was in the clear, Chuck Stravin received the news that some nodules in both of his lungs were growing at an aggressive pace. When those were removed and biopsied, results confirmed that his kidney cancer had become metastatic. “Everything switched in … Read more

The abortion pill mifepristone has been on uncertain legal ground ever since a Texas judge ruled that the U.S. Food and Drug Administration (FDA)’s approval more than two decades ago should be suspended. After the Department of Justice appealed the decision and requested that the Supreme Court step in, the high court decided that mifepristone … Read more